Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP

Clinical trial NCT07493109 · RECRUITING

Trial details

NCT number: NCT07493109
Sponsor: Ou Bai, MD/PHD
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma (DLBCL)

Start date: 2026-05-30
Primary completion: 2029-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.